research use only

Danuglipron (PF-06882961) GLP-1 Receptor agonist

Name: Danuglipron (PF-06882961)
Brand: Selleck Chemicals
SKU: S9851
Availability: InStock
Rating: 5 (1 reviews)

Cat.No.S9851

Danuglipron (PF-06882961) is a non-peptide agonist that activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33^ECD.

Danuglipron (PF-06882961) GLP-1 Receptor agonist Chemical Structure

Quality Control

Batch: Purity: 99.87%

99.87

Related Targets	CXCR Hedgehog/Smoothened PKA Adrenergic Receptor AChR 5-HT Receptor Histamine Receptor Dopamine Receptor Ras KRas
Other GLP-1 Receptor Inhibitors	Exenatide Acetate (Exendin-4) Survodutide Ecnoglutide（XW003） AZD5004 (ECC5004) Brenipatide CT-996(RO7795081，RG6652） Ribupatide

Solubility

In vitro
Batch:

Ethanol : 100 mg/mL

DMSO : 10 mg/mL (17.99 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
Mass value Mass unit	Concentration value Concentration unit	Volume value Volume unit	Molecular weight (g/mol)

Dilution Calculator Molecular Weight Calculator

In vivo batch selection In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	5.000mg/ml (9.00mM)	Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Clear solution	5% DMSO 1 95% Corn oil Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	0.800mg/ml (1.44mM)	Taking the 1 mL working solution as an example, add 50 μL of 16 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg

Average weight of animals: g

Dosing volume per animal: μL

Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO

% Tween 80

% ddH₂O

% DMSO

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight	555.60	Formula	C₃₁H₃₀FN₅O₄	Storage (From the date of receipt)	3 years -20°C powder
CAS No.	2230198-02-2	--		Storage of Stock Solutions	1 year-80°Cin solvent 1 month-20°Cin solvent
Synonyms	N/A			SMILES	OC(=O)C1=CC=C2N=C(CN3CCC(CC3)C4=NC(=CC=C4)OCC5=C(F)C=C(C=C5)C#N)[N](CC6CCO6)C2=C1

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC₅₀/Ki	GLP-1 receptor
In vitro	Danuglipron (PF-06882961) stimulates cAMP accumulation in CHO cells expressing both the human and monkey GLP-1Rs with comparable EC50 values. In contrast, it does not increase cAMP levels in cells expressing the mouse, rat, or rabbit GLP-1R.
In vivo	Danuglipron (PF-06882961) potentiates glucose-stimulated insulin release and reduces food intake in monkeys.
References	[1] https://pubmed.ncbi.nlm.nih.gov/33677922/ [2] https://www.biorxiv.org/content/10.1101/2020.09.29.319483v1.full

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-08-07)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT06910839	TERMINATED	Overweight; Obesity	Pfizer	2025-03-13	PHASE1
NCT06567327	COMPLETED	Obesity	Pfizer	2024-08-28	PHASE1
NCT06541678	COMPLETED	Healthy	Pfizer	2024-12-23	PHASE1
NCT06568731	COMPLETED	Obesity	Pfizer	2024-08-23	PHASE1
NCT06153758	COMPLETED	Healthy Participants; Healthy Subjects	Pfizer	2023-11-27	PHASE1
NCT04707313	COMPLETED	Obesity	Pfizer	2021-01-29	PHASE2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):